Japan Venture Taps ‘Deep Learning’ To Improve Drug Discovery
This article was originally published in PharmAsia News
Executive Summary
The Japanese peptide venture Interprotein is tapping into artificial intelligence technology with the hope of improving the efficiency and accuracy of its drug discovery efforts.